A federal judge has struck down a Trump administration rule that allowed health insurers to exclude drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs.
Under the Trump rule, these “copay accumulator” policies meant patients generally paid more out of pocket for their prescription drugs.
